Joseph P Casazza
4PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 01, 2025
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem-specific human B cells.Grace E Mantus, Ankita J Chopde, Jason Gorman
|Sep 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner
|Jun 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.Wanwisa Promsote, Ling Xu, Jason Hataye
|Apr 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.Joseph P Casazza, Evan M Cale, Sandeep Narpala
Pageof 1
Frequent Collaborators
3 joint publications
Adrian McDermott
2 joint publications
Lesia K Dropulic
2 joint publications
Gary J Nabel
2 joint publications
Masaru Kanekiyo
2 joint publications
Sarah F Andrews
1 joint publications
Alicia T Widge
1 joint publications
Xuejun Chen
1 joint publications
Peter D Kwong
1 joint publications
Alejandro B Balazs
1 joint publications
Jason Hataye
